Sylvia Ma
Publications by Year
Research Areas
Cancer therapeutics and mechanisms, Synthesis and biological activity, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, Pharmacological Effects of Natural Compounds
Most-Cited Works
- → CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons In vitro and In vivo(2007)149 cited
- → Optimization of a Dibenzodiazepine Hit to a Potent and Selective Allosteric PAK1 Inhibitor(2015)103 cited
- → Design and Synthesis of Orally Bioavailable Benzimidazoles as Raf Kinase Inhibitors(2008)76 cited
- → 4-(Aminoalkylamino)-3-benzimidazole-quinolinones as potent CHK-1 inhibitors(2006)70 cited
- A Comparative Analysis of Determinant Attributes in Retail Store Selection(1978)
- → Design and structure–activity relationship of 3-benzimidazol-2-yl-1H-indazoles as inhibitors of receptor tyrosine kinases(2006)45 cited
- → Design and Discovery of N-(2-Methyl-5′-morpholino-6′-((tetrahydro-2H-pyran-4-yl)oxy)-[3,3′-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant Cancers(2017)44 cited
- → Discovery of 2-pyrimidyl-5-amidothiophenes as potent inhibitors for AKT: Synthesis and SAR studies(2006)43 cited
- → Rationally Designed PI3Kα Mutants to Mimic ATR and Their Use to Understand Binding Specificity of ATR Inhibitors(2017)40 cited
- → Two Distinct Mechanisms of Inhibition of LpxA Acyltransferase Essential for Lipopolysaccharide Biosynthesis(2020)39 cited